From: Prognostic assessment for patients with cancer and incidental pulmonary embolism
N* | OS (95%CI) | p | HR(95%CI) | p | |
---|---|---|---|---|---|
Metastatic/incurable disease | |||||
No | 45 | <.001 | 1 | <.001 | |
Yes | 188 | NR 10.5 (7.3, 13.7) | 2.6 (1.5, 4.3) | ||
New Symptoms | |||||
No | 132 | 17 (12.7, 21.3) | .029 | ||
Yes | 98 | 10.1 (5.9, 14.3) | |||
Worsening Symptoms | |||||
No | 178 | 15.2 (11.9, 8.4) | |||
Yes | 49 | 6.5 (5.2, 7.8) | .013 | ||
New or Worsening symptoms | |||||
No | 111 | 19 (14.3, 23.8) | .004 | 1 | .002 |
Yes | 121 | 8.6 (5.3, 11.8) | 1.7 (1.2, 2.4) | ||
WCC | |||||
<11.3 x109/L | 199 | 14 (9.9, 18.1) | .016 | 1 | |
≥11.3 x109/L | 26 | 5.4 (2.4,8.3) | 1.1 (.7, 1.8) | .659 | |
Creatinine | |||||
<55μmol/L | 29 | 5.3 (1.5, 9.2) | .021 | 1 | .408 |
>55μmol/L | 195 | 14 (10, 17.9) | 1.2 (.8, 2) | ||
ECOG/WHO PS | <.001 | <.001 | |||
0 | 104 | 22.9 (17.9, 28.3) | 1 | ||
1,2 | 100 | 8.8 (6.5, 11) | <.001 | 1.9 (1.3, 2.8) | .001 |
3,4 | 23 | 3.3 (2.2, 4.4) | <.001 | 3.7 (2.2, 6.3) | <.001 |
PESI | <.001 | .081 | |||
I,II | 28 | 21 (6.2, 35.7) | 1 | ||
III,IV | 185 | 13.8 (10.5, 17.1) | .222 | 1.5 (.8, 2.5) | .181 |
V | 20 | 5.5 (4.3, 6.6) | <.001 | 2.3 (1.1, 4.8) | .026 |